uniQure N.V. (QURE) - 5i Research

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

AbbVie Inc. (ABBV $229.31)
- $229.31 P/E (TTM): 175.05X Cap: $405.27B
- View ABBV Profile
- View Questions on ABBV
Eli Lilly and Company (LLY $1,080.36)
- $1,080.36 P/E (TTM): 52.86X Cap: $1.02T
- View LLY Profile
- View Questions on LLY
Cipher Pharmaceuticals Inc. (CPH $14.90)
- $14.90 P/E (TTM): 16.21X Cap: $378M
- View CPH Profile
- View Questions on CPH
- View Reports on CPH
Halozyme Therapeutics Inc. (HALO $70.31)
- $70.31 P/E (TTM): 16.09X Cap: $8.26B
- View HALO Profile
- View Questions on HALO
uniQure N.V. (QURE $23.39)
- $23.39 Cap: $1.52B
- View QURE Profile
- View Questions on QURE
Catalyst Pharmaceuticals Inc. (CPRX $23.15)
- $23.15 P/E (TTM): 13.46X Cap: $2.84B
- View CPRX Profile
- View Questions on CPRX

Q: Hi, could you suggest a couple each of your fav. small, mid and large cap biotech stocks and why you like them.

thanks, M

Read Answer Asked by Mark on October 08, 2025

Q: What do you think of the prospects for these companies; ITRM, QURE, CEIX

Read Answer Asked by hal on August 10, 2023